Elevance Health Inc (ELV) Actualités

Elevance Health Announces Appearance at UBS Global Healthcare Conference

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho...

Elevance Health Appoints Nathan Rich Vice President, Investor Relations

Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In...

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elevance Health Reports Third Quarter 2024 Results

3Q 2024 operating revenue of $44.7 billion 3Q 2024 adjusted operating gain1 of $2.4 billion 3Q 2024 diluted EPS2 of $4.36; adjusted diluted EPS1...

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2024 Results on October 17, 2024

Elevance Health (NYSE: ELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”...

Form 4 - Statement of changes in beneficial ownership of securities

Elevance Health Responds to Communities Affected by Hurricane Helene

Grant to support communities in recovery and rebuilding Elevance Health and its philanthropic arm, Elevance Health Foundation, are committed to...

Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health

Whole Health Index is an industry-leading calculation for defining and measuring the most powerful drivers of...